Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07268846 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery

Study acronym: POSBIO-CRC
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
AC Camargo Cancer Center
10 trials monitored
See all monitored trials
Breast Cancer
5,418 trials monitored
See 296 trials at risk
Colorectal Cancer
3,394 trials monitored
See 159 trials at risk
Leukemia
2,948 trials monitored
See 180 trials at risk
and 1 more disease
The treatment of colorectal cancer, in the absence of metastases, is primarily based on surgical removal. Colorectal surgery, which involves resecting part of the intestine and restoring intestinal continuity, carries a risk of complications. This study aims to evaluate whether oral supplementation with a postbiotic at a dose of 900 mg for 7 days prior to surgery reduces the rate of postoperative complications.
Trial Details
NCT Number NCT07268846
Lead Sponsor AC Camargo Cancer Center
Conditions
(from sponsor)		 Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
Related terms Breast Neoplasms, Colonic Neoplasms, Colorectal Neoplasms, Inflammation, Lymphoma, Multiple Myeloma, Neoplasms
Enrollment 164 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov